These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28091333)

  • 21. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines.
    Farrell B; Richardson L; Raman-Wilms L; de Launay D; Alsabbagh MW; Conklin J
    Res Social Adm Pharm; 2018 Jan; 14(1):18-25. PubMed ID: 28214150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active deprescribing program in chronic kidney disease patients undergoing haemodialysis.
    George JS; Joseph R; Thomas ETA; John GP; Siby A; Nair MM
    Nephrology (Carlton); 2021 Nov; 26(11):890-897. PubMed ID: 34240512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences.
    Bondurant-David K; Dang S; Levy S; Sperlea D; Vanier MC; Gerardi S; David PM
    Int J Pharm Pract; 2020 Dec; 28(6):635-642. PubMed ID: 33094884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimising Medications for Patients With Cancer and Multimorbidity: The Case for Deprescribing.
    Turner JP; Kantilal K; Kantilal K; Holmes HM; Koczwara B
    Clin Oncol (R Coll Radiol); 2020 Sep; 32(9):609-617. PubMed ID: 32563549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploration of home care nurse's experiences in deprescribing of medications: a qualitative descriptive study.
    Sun W; Tahsin F; Barakat-Haddad C; Turner JP; Haughian CR; Abbass-Dick J
    BMJ Open; 2019 May; 9(5):e025606. PubMed ID: 31129579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deprescribing: An umbrella review.
    Japelj N; Horvat N; Knez L; Kos M
    Acta Pharm; 2024 Jun; 74(2):249-267. PubMed ID: 38815201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deprescribing for Better Patient Outcomes in Chronic Long Term Care and Role of Clinical Pharmacological Review.
    Samajdar SS; Mukherjee S; Tripathi SK; Pal J; Joshi S
    J Assoc Physicians India; 2021 Nov; 69(11):11-12. PubMed ID: 34781620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A-TAPER: A Framework for Deprescribing Medications effectively.
    Armistead LT; Sanders KA; Larson CK; Busby-Whitehead J; Ferreri SP
    Res Social Adm Pharm; 2022 Aug; 18(8):3358-3361. PubMed ID: 34930683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Older Adults' Awareness of Deprescribing: A Population-Based Survey.
    Turner JP; Tannenbaum C
    J Am Geriatr Soc; 2017 Dec; 65(12):2691-2696. PubMed ID: 28913911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appropriate deprescribing in older people: a challenging necessityCommentary to accompany themed collection on deprescribing.
    van der Velde N; Minhas JS
    Age Ageing; 2021 Sep; 50(5):1516-1519. PubMed ID: 34260681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers and enablers to deprescribing in long-term care facilities: a 'best-fit' framework synthesis of the qualitative evidence.
    Heinrich CH; Hurley E; McCarthy S; McHugh S; Donovan MD
    Age Ageing; 2022 Jan; 51(1):. PubMed ID: 35077555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deprescribing as a Clinical Improvement Focus.
    Dharmarajan TS; Choi H; Hossain N; Munasinghe U; Lakhi F; Lourdusamy D; Onuoha S; Murakonda P; Skokowska-Lebelt A; Kanagala M; Russell RO
    J Am Med Dir Assoc; 2020 Mar; 21(3):355-360. PubMed ID: 31672564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are residents of aged care facilities willing to have their medications deprescribed?
    Kalogianis MJ; Wimmer BC; Turner JP; Tan EC; Emery T; Robson L; Reeve E; Hilmer SN; Bell JS
    Res Social Adm Pharm; 2016; 12(5):784-8. PubMed ID: 26850702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing Medication Use Through Deprescribing: Tactics for This Approach.
    Brandt NJ
    J Gerontol Nurs; 2016 Jan; 42(1):10-4. PubMed ID: 26866398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deprescribing to Reduce Medication Use: Will This Help Your Patient?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2016 Nov; 54(11):21-24. PubMed ID: 27805712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geriatric Polypharmacy: Two Physicians' Personal Perspectives.
    Chen Z; Buonanno A
    Clin Geriatr Med; 2017 May; 33(2):283-288. PubMed ID: 28364996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.
    Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D
    Int J Clin Pharm; 2015 Oct; 37(5):949-57. PubMed ID: 26047944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol.
    Simões PA; Santiago LM; Simões JA
    BMJ Open; 2018 Jul; 8(7):e019542. PubMed ID: 30018092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
    Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
    Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.